A massive intraventricular thrombosis by disseminated mucormycosis in a patient with myelodysplastic syndrome during deferoxamine therapy.
Kubota
Naoshi
N
First Department of Internal Medicine, Second Department of Pathology, Tokyo Medical University, Japan.
Miyazawa
Keisuke
K
Shoji
Nahoko
N
Sumi
Masahiko
M
Nakajima
Akihiro
A
Kimura
Yukihiko
Y
Oshiro
Hisashi
H
Ebihara
Yoshiro
Y
Ohyashiki
Kazuma
K
D000368:Aged; D002551:Cerebral Ventricle Neoplasms / Q000150:complications* / Q000382:microbiology / Q000473:pathology; D002552:Cerebral Ventricles / Q000382:microbiology* / Q000473:pathology; D003676:Deferoxamine / Q000009:adverse effects* / Q000627:therapeutic use*; D017809:Fatal Outcome; D006801:Humans; D008297:Male; D009090:Mucorales / Q000302:isolation & purification; D009091:Mucormycosis / Q000150:complications* / Q000209:etiology*; D009190:Myelodysplastic Syndromes / Q000188:drug therapy*; D009894:Opportunistic Infections / Q000150:complications; D013927:Thrombosis / Q000209:etiology* / Q000473:pathology
D003676:Deferoxamine